Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Talaris Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  0.00.00.013.4
            Revenue growth    -100.0% 
Cost of goods sold  0.00.00.026.7
Gross profit  0.00.00.0-13.4
            Gross margin     -100.0%
Selling, general and administrative   [+]76.547.522.75.0
Other operating expenses  -76.5-47.5-22.7 
EBITDA   [+]1.40.60.4-18.0
            EBITDA margin     -134.6%
Depreciation and amortization  1.40.60.40.4
EBIT   [+]0.00.00.0-18.4
            EBIT margin     -137.5%
Other income (expense), net  -73.9-47.8-22.70.2
Pre-tax income  -73.9-47.8-22.7-18.2
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -73.9-47.8-22.70.0
            Net margin     -0.1%
   
Basic EPS   [+]($1.79)($1.64)($3.40)($2.84)
Diluted EPS   [+]($1.79)($1.64)($3.40)($2.84)
   
Shares outstanding (basic)   [+]41.229.16.70.0
Shares outstanding (diluted)   [+]41.229.16.70.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy